Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aurora Cannabis Inc. (ACB) vs Journey Medical Corporation (DERM)

Aurora Cannabis Inc. and Journey Medical Corporation are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. is the larger, with a market value of $267.8M against $178.4M — 1.5× the size. Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against −18.2%. Journey Medical Corporation has the higher net margin (−8.95% vs −38.1%) and the lower return on invested capital (−5.89% vs −5.58%). Across the 18 metrics below, Journey Medical Corporation leads on 11 and Aurora Cannabis Inc. on 7.

Valuation

Metric ACB DERM Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.20 2.48 2.25
P/B 0.66 5.26 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 96.75 12.29
EV/Sales 0.96 2.47 2.56
Earnings yield (34.39%) (3.58%) (2.99%)
Free cash flow yield (14.28%) (13.32%) 0.00%

Profitability

Metric ACB DERM Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 65.45% 53.94%
Operating margin (12.13%) (4.41%) 0.00%
Net margin (38.12%) (8.95%) 0.00%
Free cash flow margin (17.19%) (10.99%) 0.00%
Return on equity (19.85%) (23.77%) (0.40%)
Return on assets (15.19%) (6.80%) (3.32%)
Return on invested capital (5.58%) (5.89%) 0.00%

Growth

Metric ACB DERM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 20.89% 10.01%
EPS growth (last fiscal year) (5,266.67%) 34.72% —
Revenue growth, 5-year CAGR 3.92% 6.79% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB DERM Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.79 0.05
Current ratio 5.36 1.59 2.31
Net debt to EBITDA 5.11 (0.35) 0.85

Dividend

Metric ACB DERM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ACB DERM Drug Manufacturers Specialty & Generic median
Market cap 267.79m 178.38m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack